Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Dec;35(12):2882.e7-2882.e12.
doi: 10.1016/j.neurobiolaging.2014.07.012. Epub 2014 Jul 18.

Genetic architecture of ALS in Sardinia

Affiliations

Genetic architecture of ALS in Sardinia

Giuseppe Borghero et al. Neurobiol Aging. 2014 Dec.

Abstract

Conserved populations, such as Sardinians, displaying elevated rates of familial or sporadic amyotrophic lateral sclerosis (ALS) provide unique information on the genetics of the disease. Our aim was to describe the genetic profile of a consecutive series of ALS patients of Sardinian ancestry. All ALS patients of Sardinian ancestry, identified between 2008 and 2013 through the Italian ALS Genetic Consortium, were eligible to be included in the study. Patients and controls underwent the analysis of TARDBP, C9ORF72, SOD1, and FUS genes. Genetic mutations were identified in 155 out of 375 Sardinian ALS cases (41.3%), more commonly the p.A382T and p.G295S mutations of TARDBP and the GGGGCC hexanucleotide repeat expansion of C9ORF72. One patient had both p.G295S and p.A382T mutations of TARDBP and 8 carried both the heterozygous p.A382T mutation of TARDBP and a repeat expansion of C9ORF72. Patients carrying the p.A382T and the p.G295S mutations of TARDBP and the C9ORF72 repeat expansion shared distinct haplotypes across these loci. Patients with cooccurrence of C9ORF72 and TARDBP p.A382T missense mutation had a significantly lower age at onset and shorter survival. More than 40% of all cases on the island of Sardinia carry a mutation of an ALS-related gene, representing the highest percentage of ALS cases genetically explained outside of Scandinavia. Clinical phenotypes associated with different genetic mutations show some distinctive characteristics, but the heterogeneity between and among families carrying the same mutations implies that ALS manifestation is influenced by other genetic and nongenetic factors.

Keywords: Amyotrophic lateral sclerosis; Genetics; Penetrance; Phenotype; Prognosis; Sardinia.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Adriano Chiò serves on a scientific advisory board for Biogen Idec, Cytokinetics, and Italfarmaco. Borghero, Pugliatti, F. Marrosu, M.G Marrosu, Murru, Floris, Cannas, Parish, Occhineri, Cau, Loi, Ticca, Manera, Canosa, Moglia, Calvo, Barberis, Brunetti, Pliner, Renton, Nalls, Traynor, Restagno report no conflicts of interest.

The sponsor organizations had no role in data collections and analysis and did not participate to writing and approving the manuscript. The information reported in the manuscript has never been reported elsewhere.

Figures

Figure 1
Figure 1
Geographic distribution of area of origin of parents of Sardinian ALS cases according to more common mutations. The two TARDBP p.A382T homozygous patients and the single patients with double p.A382T and p.G295S heterozygous mutations are included in the TARDBP figures. The 8 patients with double mutation (C9ORF72 & p.A382T TARDBP) were included in both C9ORF72 and TARDBP figures.
Figure 2
Figure 2
Cumulative probability of ALS onset according to genetic status of Sardinian patients. Brown, no detected mutations; violet, TARDBP p.A382T heterozygous mutations; green, C9ORF72 mutations; red, TARDBP p.G295S heterozygous mutations; yellow, double C9ORF72 and TARDBP p.A382T heterozygous mutations.
Figure 3
Figure 3
Kaplan-Meier curves (tracheostomy-free survival) of ALS Sardinian patients with different genetic mutations. Brown, no detected mutations; violet, TARDBP p.A382T heterozygous mutations; green, C9ORF72 mutations; red, TARDBP p.G295S heterozygous mutations; yellow, double C9ORF72 and TARDBP p.A382T heterozygous mutations.

References

    1. Borghero G, Floris G, Cannas A, Marrosu MG, Murru MR, Costantino E, Parish LD, Pugliatti M, Ticca A, Traynor BJ, Calvo A, Cammarosano S, Moglia C, Cistaro A, Brunetti M, Restagno G, Chiò A. A patient carrying a homozygous p.A382T TARDBP missense mutation shows a syndrome including ALS, extrapyramidal symptoms, and FTD. Neurobiol Aging. 2011;32:2327.e1–2327.e5. - PMC - PubMed
    1. Brooks BR, Miller RG, Swash M, Munsat TL World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–299. - PubMed
    1. Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, Hardiman O. Proposed criteria for familial amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2011;12:157–155. - PubMed
    1. Cannas A, Borghero G, Floris GL, Solla P, Chiò A, Traynor BJ, Calvo A, Restagno G, Majounie E, Costantino E, Piras V, Lavra L, Pani C, Orofino G, Di Stefano F, Tacconi P, Mascia MM, Muroni A, Murru MR, Tranquilli S, Corongiu D, Rolesu M, Cuccu S, Marrosu F, Marrosu MG. The p.A382T TARDBP gene mutation in Sardinian patients affected by Parkinson's disease and other degenerative parkinsonisms. Neurogenetics. 2013;14:161–166. - PMC - PubMed
    1. Chiò A, Borghero G, Restagno G, Mora G, Drepper C, Traynor BJ, Sendtner M, Brunetti M, Ossola I, Calvo A, Pugliatti M, Sotgiu MA, Murru MR, Marrosu MG, Marrosu F, Marinou K, Mandrioli J, Sola P, Caponnetto C, Mancardi G, Mandich P, La Bella V, Spataro R, Conte A, Monsurrò MR, Tedeschi G, Pisano F, Bartolomei I, Salvi F, Lauria Pinter G, Simone I, Logroscino G, Gambardella A, Quattrone A, Lunetta C, Volanti P, Zollino M, Penco S, Battistini S the ITALSGEN consortium. Renton AE, Majounie E, Abramzon Y, Conforti FL, Giannini F, Corbo M, Sabatelli M. Clinical characteristics of familial ALS patients carrying the pathogenic GGGGCC hexanucleotide repeat expansion of the C9ORF72 gene. Brain. 2012a;135:784–793. - PMC - PubMed

Publication types